Caldwell Trust CO Bristol Myers Squibb CO Transaction History

Caldwell Trust CO

$1.07 Trillion
Q3 2025

A detailed history of Caldwell Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Caldwell Trust CO holds 35,171 shares of BMY stock, worth $1.64 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

35,171

Previous 36,629 3.98%

Holding current value

$1.64 Million

Previous $1.7 Billion 6.45%

% of portfolio

0.15%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$43.31 - $48.98 $63,145 - $71,412	-1,458 Reduced 3.98%	35,171 $1.59 Billion
Q2 2025 Sep 22, 2025	BUY	$44.12 - $59.6 $1.62 Million - $2.18 Million	36,629 New	36,629 $1.7 Billion
Q1 2025 Sep 23, 2025	BUY	$53.9 - $63.11 $65,165 - $76,299	1,209 Added 3.3%	37,838 $2.31 Billion
Q4 2024 Sep 24, 2025	SELL	$51.92 - $59.94 $65,626 - $75,764	-1,264 Reduced 3.24%	37,703 $2.13 Billion
Q3 2024 Sep 24, 2025	SELL	$39.66 - $51.75 $56,753 - $74,054	-1,431 Reduced 3.54%	38,967 $2.02 Billion
Q2 2024 Sep 24, 2025	SELL	$40.25 - $52.99 $29,785 - $39,212	-740 Reduced 1.8%	40,398 $1.68 Billion
Q1 2024 Sep 24, 2025	BUY	$47.98 - $54.4 $216,341 - $245,289	4,509 Added 12.31%	41,138 $2.23 Billion
Q4 2023 Oct 01, 2025	SELL	$48.48 - $57.85 $137,828 - $164,467	-2,843 Reduced 6.15%	43,350 $2.22 Billion
Q3 2023 Oct 01, 2025	SELL	$57.89 - $64.73 $164,465 - $183,897	-2,841 Reduced 5.79%	46,193 $2.68 Billion
Q2 2023 Oct 01, 2025	SELL	$63.71 - $70.74 $75,305 - $83,614	-1,182 Reduced 2.35%	49,034 $3.14 Billion
Q1 2023 Oct 01, 2025	BUY	$65.71 - $74.53 $892,801 - $1.01 Million	13,587 Added 37.09%	50,216 $3.48 Billion
Q4 2022 Oct 01, 2025	BUY	$68.48 - $81.09 $26,159 - $30,976	382 Added 0.75%	51,374 $3.7 Billion
Q3 2022 Oct 01, 2025	BUY	$0.13 - $76.84 $1,867 - $1.1 Million	14,363 Added 39.21%	50,992 $3.63 Billion
Q2 2022 Oct 01, 2025	BUY	$72.62 - $79.98 $256,493 - $282,489	3,532 Added 7.26%	52,201 $4.02 Billion
Q1 2022 Oct 01, 2025	BUY	$61.48 - $73.72 $740,219 - $887,588	12,040 Added 32.87%	48,669 $3.55 Billion
Q4 2021 Oct 02, 2025	SELL	$53.63 - $62.52 $50,948 - $59,394	-950 Reduced 1.89%	49,247 $3.07 Billion
Q3 2021 Oct 02, 2025	SELL	$59.17 - $69.31 $175,261 - $205,296	-2,962 Reduced 5.57%	50,197 $2.97 Billion
Q2 2021 Oct 02, 2025	SELL	$61.91 - $67.42 $80,854 - $88,050	-1,306 Reduced 2.4%	53,159 $3.55 Billion
Q1 2021 Oct 02, 2025	BUY	$59.34 - $66.74 $1.06 Million - $1.19 Million	17,836 Added 48.69%	54,465 $3.44 Billion
Q4 2020 Oct 02, 2025	BUY	$57.74 - $65.43 $1.06 Million - $1.2 Million	18,398 Added 50.23%	55,027 $3.41 Billion
Q3 2020 Oct 02, 2025	SELL	$57.43 - $63.64 $247,810 - $274,606	-4,315 Reduced 6.56%	61,433 $3.7 Billion
Q2 2020 Oct 02, 2025	BUY	$54.82 - $64.09 $657 - $769	12 Added 0.02%	65,748 $3.87 Billion
Q1 2020 Oct 02, 2025	BUY	$46.4 - $67.43 $1.35 Million - $1.96 Million	29,107 Added 79.46%	65,736 $3.66 Billion
Q4 2019 Oct 06, 2025	BUY	$49.21 - $64.19 $1.54 Million - $2 Million	31,227 Added 85.25%	67,856 $4.36 Billion

Others Institutions Holding BMY

# of Institutions

2,665

Shares Held

1.62B

Call Options Held

22.4M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caldwell Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Caldwell Trust CO with notifications on news.

Account

Caldwell Trust CO Bristol Myers Squibb CO Transaction History